Company Of The Day: Johnson & Johnson

+13.96%
Upside
158
Market
180
Trefis
JNJ: Johnson & Johnson logo
JNJ
Johnson & Johnson

What?

Johnson & Johnson (NYSE:J&J) plans to split into two publically traded companies. The first company will hold the company’s prescription-drug and medical-device businesses. The second will hold the company’s consumer businesses.

So What?

Relevant Articles
  1. Will Johnson & Johnson Stock Rebound To Its Pre-Inflation Shock Highs of $185?
  2. Should You Pick Johnson & Johnson Stock At $160?
  3. Should You Pick Johnson & Johnson Stock After A 6% Fall In A Month Despite Upbeat Q3?
  4. What’s Happening With Johnson & Johnson Stock?
  5. Johnson & Johnson Poised For A Muted Q2?
  6. Cross-Sector Comparison: Is Caterpillar Stock A Better Pick Over J&J?

While J&J’s consumer business is very high profile, it lags the pharma business in terms of growth and profitability. With the planned split, J&J could potentially unlock some value for shareholders.

See Our Complete Analysis For Johnson & Johnson

What if you’re looking for a more balanced portfolio instead? Here’s a high-quality portfolio that’s beaten the market consistently since 2016.

Invest with Trefis Market Beating Portfolios
See all Trefis Price Estimates